LivaNova PLC (LIVN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LIVN Revenue Growth
Revenue Breakdown (FY 2025)
LIVN's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
LIVN Revenue Analysis (2014–2025)
As of May 8, 2026, LivaNova PLC (LIVN) generated trailing twelve-month (TTM) revenue of $1.43 billion, reflecting strong growth of +14.3% year-over-year. The most recent quarter (Q1 2026) recorded $362.3 million in revenue, up 0.4% sequentially.
Looking at the longer-term picture, LIVN's 5-year compound annual growth rate (CAGR) stands at +8.2%, indicating steady revenue expansion. The company achieved its highest annual revenue of $1.39 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows LIVN's business is primarily driven by Cardiopulmonary Segment (57%), and Neuromodulation Segment (43%). With over half of revenue concentrated in Cardiopulmonary Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), INVA (+13.6% YoY), and GKOS (+36.3% YoY), LIVN has underperformed the peer group in terms of revenue growth. Compare LIVN vs NVCR →
LIVN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LIVNCurrent | $1.4B | +14.3% | +8.2% | 14.4% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 GKOS | $507M | +36.3% | +17.7% | -17.1% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% |
LIVN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.39B | +10.7% | $939.9M | 67.7% | $199.4M | 14.4% |
| 2024 | $1.25B | +8.7% | $870.9M | 69.5% | $129.1M | 10.3% |
| 2023 | $1.15B | +12.9% | $771.3M | 66.9% | $-68,498,000 | -5.9% |
| 2022 | $1.02B | -1.3% | $707.2M | 69.2% | $-76,752,000 | -7.5% |
| 2021 | $1.04B | +10.8% | $706.0M | 68.2% | $-784,000 | -0.1% |
| 2020 | $934.2M | -13.8% | $594.8M | 63.7% | $-273,899,000 | -29.3% |
| 2019 | $1.08B | -2.1% | $723.8M | 66.8% | $-171,554,000 | -15.8% |
| 2018 | $1.11B | +9.4% | $734.5M | 66.4% | $-248,100,000 | -22.4% |
| 2017 | $1.01B | -16.6% | $651.6M | 64.4% | $95.7M | 9.5% |
| 2016 | $1.21B | +316.3% | $704.4M | 58.0% | $-27,600,000 | -2.3% |
See LIVN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LIVN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LIVN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLIVN — Frequently Asked Questions
Quick answers to the most common questions about buying LIVN stock.
Is LIVN's revenue growth accelerating or slowing?
LIVN maintains +14.3% revenue growth, in line with its 5-year CAGR of +8.2%. TTM revenue stands at $1.4B. Growth rate remains consistent with historical average.
What is LIVN's long-term revenue growth rate?
LivaNova PLC's 5-year revenue CAGR of +8.2% reflects the sustained expansion pattern. Current YoY growth of +14.3% is near this long-term average.
How is LIVN's revenue distributed by segment?
LIVN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.